Prosecution Insights
Last updated: April 19, 2026

Taiwan Mitochondrion Applied Technology Co. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18220043 USE OF EXTRACT IN MANUFACTURING A PHARMACEUTICAL OR NON-PHARMACEUTICAL COMPOSITION FOR ENHANCING THE ACTIVITY OF MITOCHONDRIA HOFFMAN, SUSAN COE 1655 Non-Final OA Jul 10, 2023
17982805 PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR REPAIRING DAMAGED LIVER, TREATING DISEASE ASSOCIATED WITH DAMAGED LIVER AND IMPROVING FUNCTIONS OF LIVER BATES, KEENAN ALEXANDER 1631 Final Rejection Nov 08, 2022
17912336 USE OF MITOCHONDRIA TO PROMOTE WOUND REPAIR AND/OR WOUND HEALING KIM, TAEYOON 1631 Final Rejection Sep 16, 2022

Managing Taiwan Mitochondrion Applied Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month